Posted by Michael Wonder on 19 Feb 2020
New institute launched to ensure the U.S. health care system is ready for gene therapies
20 February 2020 - Industry leaders, patient advocates, researchers unite to maximise the incredible potential of transformative gene therapies
The Institute for Gene Therapies (IGT) launched today with a focus on advocating for a modernised U.S. regulatory and reimbursement framework so that gene therapies can deliver their significant potential to patients.
IGT will educate stakeholders across the healthcare community about the transformational nature of gene therapies and advocate for policies that help ensure patients who need them can benefit from them.
